ALCAR also contributes to the bioenergetics processes, therefore, it plays a vital role in mitochondrial-related disorders [25, 26]
Timeline and availability
Designed based on an in-depth understanding of incretin biology, tirzepatide can simultaneously activate GLP-1 and GIP receptors, thereby exerting synergistic effects that translate into superior outcomes in glycemic control, body weight management, and pancreatic -cell function preservation (19, 20)
Tesamorelin has the strongest evidence and has been shown to reduce visceral fat by about 15% to 20% over 6 to 12 months in adults with HIV-associated lipodystrophy
GLP-1RAs have demonstrated significant anti-colorectal cancer activity [46], with the protective effects increasing in a duration-dependent manner
Topical use is generally very well tolerated